Abstract
Drug-resistant tuberculosis (TB) remains extremely difficult to treat because there are often few remaining active medications and limited diagnostic options to detect resistance. Resistance to isoniazid is typically caused by mutations in either katG or the inhA promoter. inhA mutations confer low-level resistance to isoniazid and cross-resistance to ethionamide while katG mutations confer high-level isoniazid resistance and no cross-resistance. Line Probe Assays (LPAs) that detect mutations in katG and inhA are currently performed on all positive TB cultures in KwaZulu-Natal province, South Africa, but the frequency of inhA mutations in drug-resistant TB patients has not been examined. We sought to determine the proportion of patients who could potentially benefit from high-dose isoniazid and who may be resistant to ethionamide. We reviewed 994 LPA (Hain MTBDRplus) results at the TB reference laboratory in KwaZulu-Natal to determine the frequency of mutations in either katG or the inhA promoter. We stratified these results by drug-resistance category (i.e., MDR-TB, pre-XDR-TB, and XDR-TB) as determined by phenotypic drug-susceptibility testing. Among MDR- and XDR-TB isolates, the prevalence of inhA mutations without a concurr...Continue Reading
References
Jan 14, 1994·Science·A BanerjeeW R Jacobs
Nov 26, 2003·Antimicrobial Agents and Chemotherapy·Glenn P MorlockRobert C Cooksey
Jun 15, 2004·International Journal of Antimicrobial Agents·Laura HerreraM Soledad Jiménez
Oct 13, 2006·Journal of Medical Microbiology·Hongling GuoYing Zhang
Nov 7, 2006·Lancet·Neel R GandhiGerald Friedland
Nov 7, 2006·BMJ : British Medical Journal·Heather J ZarCarl J Lombard
Nov 24, 2007·Annual Review of Microbiology·Catherine Vilchèze, William R Jacobs
Feb 13, 2009·PLoS Medicine·Andreas SandgrenMegan B Murray
May 6, 2010·American Journal of Respiratory and Critical Care Medicine·Armand Van DeunHans L Rieder
Aug 11, 2011·The European Respiratory Journal·D FalzonM Zignol
Aug 16, 2011·Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases·Elizabeth M StreicherRobin M Warren
Dec 16, 2011·Journal of Clinical Microbiology·Violet N ChihotaRobin M Warren
Feb 26, 2014·Emerging Infectious Diseases·Neel R GandhiN Sarita Shah
May 24, 2014·The Journal of Antimicrobial Chemotherapy·Tomasz JagielskiJacek Bielecki
Jun 6, 2014·South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde·F ConradieN Ndjeka
Jul 12, 2014·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Bright VargheseSahal Al-Hajoj
Sep 10, 2014·The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease·D AbateG Ameni
Oct 16, 2015·The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease·Y Zhang, W-W Yew
Citations
Mar 8, 2016·Expert Opinion on Drug Metabolism & Toxicology·Marlanka A ZuurJan-Willem C Alffenaar
Apr 15, 2016·The Journal of Antimicrobial Chemotherapy·Elisa SchenaDaniela Maria Cirillo
Dec 23, 2016·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Emily A KendallDavid W Dowdy
Mar 28, 2017·The Lancet. Respiratory Medicine·Keertan DhedaRobin M Warren
Dec 8, 2017·Journal of Clinical Microbiology·Juliane HavlicekInes Labugger
Jul 1, 2017·American Journal of Respiratory and Critical Care Medicine·Pennan M BarryNeha Shah
Sep 9, 2016·The Cochrane Database of Systematic Reviews·Grant TheronKaren R Steingart
Dec 16, 2016·Journal of Clinical Microbiology·Y GardeeN A Ismail
Jun 9, 2017·Journal of Clinical Microbiology·Lesley ScottWendy Stevens
Apr 15, 2016·Journal of Clinical Microbiology·Ruvandhi R NathavitharanaClaudia M Denkinger
Dec 31, 2018·The American Journal of Tropical Medicine and Hygiene·Kathleen F WalshSerena P Koenig
Jan 20, 2017·The European Respiratory Journal·Ruvandhi R NathavitharanaClaudia M Denkinger
Oct 10, 2019·Endocrine, Metabolic & Immune Disorders Drug Targets·Manaf AlMatarFatih Köksal
Jun 2, 2017·BMC Infectious Diseases·Ngu Njei AbandaRose Gana Fomban Leke
Apr 4, 2018·Annals of Laboratory Medicine·Joonhong ParkChunhwa Ihm
Oct 12, 2018·Tuberculosis and Respiratory Diseases·Joo Hee LeeTae Sun Shim
Nov 30, 2018·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Devyani DeshpandeTawanda Gumbo
Oct 23, 2018·Evolutionary Applications·Quang Huy NguyenAnne-Laure Bañuls
May 6, 2020·Lung India : Official Organ of Indian Chest Society·Ashok Singh CharanManisha Singh
May 31, 2018·PloS One·Edgar KigoziDavid Patrick Kateete
Dec 22, 2020·Journal of Biomolecular Structure & Dynamics·Mohd ShahbaazMostafa A Hussien
Jul 1, 2019·Revista Argentina de microbiología·Roxana SandovalMarco Galarza
Feb 9, 2021·Infection and Drug Resistance·Yanhua SongMengqiu Gao